Department of Biotechnology, Institute of Applied Medicines and Research Ghaziabad, Uttar Pradesh, India.
Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Uttar Pradesh, India.
Asian Pac J Cancer Prev. 2020 May 1;21(5):1283-1287. doi: 10.31557/APJCP.2020.21.5.1283.
ABSTRACT
Large Tumor Suppressor (LATS2) gene are Tumor Suppressor gene, linked with epigenetic modifications. LATS2 promoter hypermethylation is an important epigenetic silencing mechanism leading to cancer. Cancer is the most common, vicious and dangerously increasing diseases of the world today, associated with high morbidity and mortality. Oral cancers (OC) are the blazing universal dilemma and is the sixth most frequent cancer observed in Indian population. Tobacco consumption is the main cause of the increase in OSCC. The association between LATS2 in the pathogenesis of cancers propose that their combination might be studied as a possible molecular marker for particular subgroups of patients. Therefore, the present study tried to investigate whether LATS2 promoter methylation was associated with oral squamous cell carcinoma (OSCC) in North Indian subjects. DNA methylation quantitative studies of LATS2 Tumor Suppressor genes were performed by methylation-specific polymerase chain reaction (MSP). 38 out of 70 patients (55 %) were found to be methylated for LATS2 gene, a statistically significant result was obtained (p-value < 0.005) for LATS2 genes. The results suggest that epigenetic changes may be related to the down-regulation of LATS2 expression. It can be concluded that LATS2 gene plays a significant role in the diagnosis of cancer and provide a better alternative as a diagnostic biomarker. Our data infer that a low LATS2 expression due to methylation may contribute to the cancer progression and could be useful for the diagnosis of OSCC. Therefore, investigation of promoter methylation in such genes may provide a biomarker which may prove to be useful in early detection of Oral Cancer.
Keywords: Oral squamous cell carcinoma (OSCC), Epigenetic changes, LATS2 gene, Promoter Hypermethylation, Methylation-Specific PCR (MSP), Biomarkers
Abbreviations: OSCC- Oral Squamous Cell Carcinoma; DNA- Deoxyribonucleic acid; LATS-Large Tumor Suppressor (gene); MSP-Methylation-Specific Polymerase Chain Reaction.
摘要
LATS2 基因是一种肿瘤抑制基因,与表观遗传修饰有关。LATS2 启动子超甲基化是导致癌症的重要表观遗传沉默机制。癌症是当今世界最常见、最恶性和危险的疾病之一,与高发病率和死亡率有关。口腔癌(OC)是普遍存在的难题,也是印度人口中观察到的第六种最常见的癌症。烟草消费是 OSCC 发病率增加的主要原因。LATS2 在癌症发病机制中的作用表明,它们的组合可能被研究作为特定患者亚组的可能分子标志物。因此,本研究试图探讨 LATS2 启动子甲基化是否与印度北部患者的口腔鳞状细胞癌(OSCC)有关。通过甲基化特异性聚合酶链反应(MSP)对 LATS2 肿瘤抑制基因的 DNA 甲基化进行定量研究。在 70 名患者中,有 38 名(55%)发现 LATS2 基因发生甲基化,这是一个具有统计学意义的结果(p 值<0.005)。结果表明,表观遗传变化可能与 LATS2 表达下调有关。可以得出结论,LATS2 基因在癌症的诊断中起着重要作用,并为诊断生物标志物提供了更好的选择。我们的数据推断,由于甲基化导致 LATS2 表达降低可能有助于癌症的进展,并且可能对 OSCC 的诊断有用。因此,对这些基因的启动子甲基化进行研究可能提供一种生物标志物,这可能有助于早期发现口腔癌。
关键词:口腔鳞状细胞癌(OSCC),表观遗传变化,LATS2 基因,启动子超甲基化,甲基化特异性聚合酶链反应(MSP),生物标志物
缩写:OSCC-口腔鳞状细胞癌;DNA-脱氧核糖核酸;LATS-大型肿瘤抑制物(基因);MSP-甲基化特异性聚合酶链反应。